• Protein, Total, 24 Hour, Urine
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • Vitamin K Epoxide Reductase Complex, Subunit 1 (VKORC1) Genotyping
  • Cytochrome P450 4F2 (CYP4F2) Genotyping
  • Muscular Dystrophies Gene Mutation Panel, NGS
  • Anthrax DNA by Molecular Method
  • IKBKAP (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B-cells, Kinase Complex-associated Protein) Gene Mutation Analysis
  • ASXL1 Gene Mutation Analysis
  • Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis
  • Apolipoprotein A-II (APOA2) Gene Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

Methodology
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.